SCHEMBL1240977

SCHEMBL1240977

CO[C@H]1CCN(Cc2ccc(Br)cc2)C1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.54
BCHE P06276 2/20 0.50
ACHE P22303 2/20 0.50
BACE1 P56817 2/20 0.50
CARM1 Q86X55 1/20 0.47
PRMT6 Q96LA8 1/20 0.47
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CDC7 O00311 1/20 0.46
PIM1 P11309 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
OPRM1 P35372 3/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1240978 1.00 LTA4H (0.54) LTA4HBCHEACHEBACE1CARM1
SCHEMBL1241949 1.00 LTA4H (0.54) LTA4HBCHEACHEBACE1CARM1
SCHEMBL4592208 0.91 LTA4H (0.50) LTA4HBCHEACHEBACE1KDM4E
SCHEMBL1428200 0.90 KDM4E (0.53) LTA4HBCHEACHEBACE1CARM1
SCHEMBL18491559 0.87 LTA4H (0.50) LTA4HBCHEACHEBACE1KDM4E
SCHEMBL18082551 0.86 LTA4H (0.55) LTA4HBCHEACHEBACE1ALDH1A1
SCHEMBL13343762 0.84 LTA4H (0.54) LTA4HALDH1A1OPRM1HRH3SIGMAR1
SCHEMBL4288563 0.84 LTA4H (0.54) LTA4HALDH1A1OPRM1HRH3SIGMAR1
SCHEMBL4512639 0.84 LTA4H (0.60) LTA4HBCHEACHEBACE1ALDH1A1
SCHEMBL3271398 0.84 LTA4H (0.60) LTA4HBCHEACHEBACE1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879808-B2 potent activity against resistant pneumococci; for treating domestic fowl MEIJI SEIKA KAISHA, LTD. (JP) 2011-02-01 US disclosed
US-20100210570-A1 LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA LTD. (JP) 2010-08-19 US disclosed
EP-2151447-A1 LINCOMYCIN DERIVATIVES AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT Meiji Seika Kaisha Ltd. (JP) 2010-02-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210570-A1 LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT LAS1L, LCLAT1, LYPLA1 LTA4H 558/4885BCHE 3968/4885ACHE 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.